These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 22958493)

  • 81. Telmisartan inhibits AGE-induced podocyte damage and detachment.
    Fukami K; Yamagishi S; Kaifu K; Matsui T; Kaida Y; Ueda S; Takeuchi M; Asanuma K; Okuda S
    Microvasc Res; 2013 Jul; 88():79-83. PubMed ID: 23648312
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus.
    Suyama M; Miyazaki Y; Matsusaka T; Sugano N; Ueda H; Kawamura T; Ogura M; Yokoo T
    Clin Exp Nephrol; 2018 Apr; 22(2):266-274. PubMed ID: 28776225
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
    An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
    Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
    Guo K; Pan P; Wu M; Ma Y; Lu J; Chen H
    Mol Cell Endocrinol; 2020 Apr; 505():110730. PubMed ID: 31981598
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
    Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
    Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
    Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
    J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A.
    Carranza K; Veron D; Cercado A; Bautista N; Pozo W; Tufro A; Veron D
    Nefrologia; 2015; 35(2):131-8. PubMed ID: 26300505
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes.
    Cheng CL; Tang Y; Zheng Z; Liu X; Ye ZC; Wang C; Lou TQ
    Clin Invest Med; 2012 Oct; 35(5):E282. PubMed ID: 23043709
    [TBL] [Abstract][Full Text] [Related]  

  • 90. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
    Wang Y; Li H; Song SP
    Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
    Guan F; Villegas G; Teichman J; Mundel P; Tufro A
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy.
    Patel L; Thaker A
    Ren Fail; 2014 Jul; 36(6):916-24. PubMed ID: 24678970
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Implications of treatment that target protective mechanisms against diabetic nephropathy.
    Mima A; Qi W; King GL
    Semin Nephrol; 2012 Sep; 32(5):471-8. PubMed ID: 23062988
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.
    Logue OC; McGowan JW; George EM; Bidwell GL
    Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):404-9. PubMed ID: 27367910
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Advanced glycation end products and insulin resistance in diabetic nephropathy.
    Parwani K; Mandal P
    Vitam Horm; 2024; 125():117-148. PubMed ID: 38997162
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy.
    Yang J; Liu Z
    Front Endocrinol (Lausanne); 2022; 13():816400. PubMed ID: 35692405
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Insulin directly stimulates VEGF-A production in the glomerular podocyte.
    Hale LJ; Hurcombe J; Lay A; Santamaría B; Valverde AM; Saleem MA; Mathieson PW; Welsh GI; Coward RJ
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F182-8. PubMed ID: 23698113
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Case of Rapidly Progressive Diabetic Nephropathy Induced by Osimertinib.
    Karasawa K; Akiyama KI; Akihisa T; Miyabe Y; Nitta K; Hoshino J
    Case Rep Nephrol Dial; 2023; 13(1):104-112. PubMed ID: 37900932
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.
    Nakagawa T; Sato W; Kosugi T; Johnson RJ
    J Diabetes Res; 2013; 2013():184539. PubMed ID: 24386643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.